EUObserver reports that the European Medicines Agency has reversed its long-held stance on releasing studies on drug side effects after pressure from the European Ombudsman. The London-based agency, which evaluates drugs in the EU, on Wednesday (11 August) said that it would issue data on anti-acne medication Roaccutane produced by pharma giant Roche in the coming weeks.
Read more here: http://euobserver.com/9/30613/?rk=1
I'm Available to Speak at Your Meeting - 2026 Update
-
By way of background, I've been speaking on information management-related
topics since around 2000. I've been privileged to speak at AIIM 2003 -
2025, mor...
1 day ago
No comments:
Post a Comment